Panacea Biotec Ltd

Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

06:36 PM, 7th Jan 2026

We are now delighted to inform you that enrolment of study participants in context of DengiAll Phase-III clinical trial has been completed.